H
Harit Chaturvedi
Researcher at Max Healthcare
Publications - 36
Citations - 424
Harit Chaturvedi is an academic researcher from Max Healthcare. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 9, co-authored 33 publications receiving 237 citations. Previous affiliations of Harit Chaturvedi include Max Super Speciality Hospital & Maulana Azad Medical College.
Papers
More filters
Journal ArticleDOI
Impact of COVID-19 on cancer care in India: a cohort study.
Priya Ranganathan,Manju Sengar,Girish Chinnaswamy,Gaurav Agrawal,Rajkumar Arumugham,Rajiv G. Bhatt,Ramesh Bilimagga,Jayanta Chakrabarti,Arun Chandrasekharan,Harit Chaturvedi,Rajiv Choudhrie,Mitali Dandekar,Ashok Kumar Das,Vineeta Goel,Caleb Harris,Sujai Hegde,Narendra Hulikal,Deepa Joseph,Rajesh Kantharia,Azizullah Hafizullah Khan,Rohan Kharde,Navin Khattry,Maqbool Lone,Umesh Mahantshetty,Hemant Malhotra,Hari Menon,Deepti Mishra,Rekha A Nair,Shashank J. Pandya,Nidhi Patni,Jeremy Pautu,Simon Pavamani,Satyajit Pradhan,Subramanyeshwar Rao Thammineedi,G. Selvaluxmy,Krishna Sharan,B. K. Sharma,Jayesh Sharma,Suresh Singh,Gowtham Chandra Srungavarapu,R Subramaniam,Rajendra Toprani,Ramanan Venkat Raman,Rajendra A. Badwe,C S Pramesh +44 more
TL;DR: In this article, the authors did an ambidirectional cohort study at 41 cancer centres across India that were members of the National Cancer Grid of India to compare provision of oncology services between March 1 and May 31, 2020, with the same time period in 2019.
Journal ArticleDOI
Choosing Wisely India: ten low-value or harmful practices that should be avoided in cancer care.
C.S. Pramesh,Harit Chaturvedi,Vijay Anand Reddy,Tapan Saikia,Sushmita Ghoshal,Mrinalini Pandit,K Govind Babu,K V Ganpathy,Dhairyasheel Savant,Gunita Mitera,Richard Sullivan,Christopher M. Booth +11 more
TL;DR: A multidisciplinary framework-driven consensus process to identify a list of low-value or harmful cancer practices that are frequently undertaken in India and recommendations pertain to diagnosis and treatment, palliative care, imaging, and system-level delivery of care.
Journal ArticleDOI
Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective.
Gouri Shankar Bhattacharyya,Dinesh Chandra Doval,Chirag Desai,Harit Chaturvedi,Sanjay Sharma,S.P. Somashekhar +5 more
TL;DR: The role of prognostic factors, the currently available biomarkers and prognostic signatures, and the importance of ethnically validating biomarker and prognosis signatures are elucidated.
Journal ArticleDOI
Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.
Dinesh Chandra Doval,Kumar Prabhash,S Patil,Harit Chaturvedi,Chanchal Goswami,Ashok K. Vaid,Subhash Desai,Shilpee Dutt,V.H. Veldore,Nirmala A. Jambhekar,Anurag Mehta,D. Hazarika,Saud Azam,S. Gawande,Sunil Gupta +14 more
TL;DR: The mutual exclusivity of EML4-ALK and EGFR mutations suggests implementation of biomarker testing for tumors harboring ALK rearrangements in order to identify patients that can benefit from newer targeted therapies.
Journal ArticleDOI
Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
Dinesh Chandra Doval,Anila Sharma,R. K. Sinha,Kapil Kumar,Ajay Kumar Dewan,Harit Chaturvedi,Ullas Batra,Vineet Talwar,Sunil Gupta,Shailendra Singh,Vidula Bhole,Anurag Mehta +11 more
TL;DR: The majority of the Indian breast cancer patients seen in the Rajiv Gandhi Cancer Institute and Research Centre present with ER and PgR positive tumors, and the triple negative patients tended to be younger, premenopausal, and were associated with higher tumor grades, negative lymph nodes status and lower frequency of ductal carcinoma in situ.